The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth

Similar Items

• Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges
  od: McFall, Thomas, i dr.
  Izdano: (2015)
• The ETS Domain Transcription Factor ELK1 Directs a Critical Component of Growth Signaling by the Androgen Receptor in Prostate Cancer Cells
  od: Patki, Mugdha, i dr.
  Izdano: (2013)
• Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells
  od: Rosati, Rayna, i dr.
  Izdano: (2016)
• Strategy for Tumor Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer
  od: Rosati, Rayna, i dr.
  Izdano: (2018)
• The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer
  od: Pardy, Luke, i dr.
  Izdano: (2019)